Solstice Oncology Launches with $225 Million Series A

Evidence Company disclosure · Discovery September 9, 2026 · Importance 5/5 · Direction Positive Summary Solstice Oncology launched with a $225 million Series A led by RA Capital Management and joined by Canaan Partners, Forbion and other investors. The company was formed in February 2026…